Skip to main content

Table 1 Antimicrobial susceptibilities of 6 epidemic Burkholderia cepacia complex isolates (P-5, P-6, P-7. P-8. and P-9) in the NICU and 2 isolates (P-a and P-B) from unrelated wards with the neg combo 3.12J panels with the MicroScan Walkaway 40 System

From: Successful cessation of transmitting healthcare-associated infections due to Burkholderia cepacia complex in a neonatal intensive care unit in a Japanese children's hospital

Patient No.# Date of Isolation day/month/year Specimen Obtained MIC(μg/ml)
  PIPC CAZ CFS CFPM CZOP AZT IPM MEPM TOB AMK GM MINO LVFX CPFX ST FOM C/S P/T
P-A 07/09/2010 bronchial aspirate > 64 > 16 > 16 > 16 > 16 > 16 > 8 < 1 > 8 > 32 > 8 < 2 2 2 < 2 > 16 > 32 < 8
P-B 13/09/2010 salivary fluid 64 4 > 16 > 16 > 16 > 16 > 8 2 > 8 > 32 > 8 4 4 > 2 > 2 > 16 > 32 < 8
P-5 14/09/2010 bronchial aspirate > 64 4 > 16 > 16 > 16 > 16 > 8 < 1 > 8 > 32 > 8 < 2 1 1 < 2 > 16 > 32 < 8
P-6a 21/09/2010 peripheral blood > 64 4 > 16 > 16 > 16 > 16 8 < 1 > 8 > 32 > 8 < 2 1 1 < 2 > 16 > 32 < 8
P-6b 12/10/2010 catheterized urine > 64 8 > 16 > 16 > 16 > 16 8 < 1 > 8 > 32 > 8 < 2 1 1 < 2 > 16 > 32 < 8
P-7 14/09/2010 bronchial aspirate 64 8 > 16 > 16 > 16 > 16 > 8 < 1 > 8 > 32 > 8 < 2 1 1 < 2 > 16 > 32 < 8
P-8 28/09/2010 bronchial aspirate > 64 4 > 16 > 16 > 16 > 16 8 < 1 > 8 > 32 > 8 < 2 1 1 < 2 > 16 > 32 < 8
P-9 18/01/2011 bronchial aspirate 64 8 > 16 > 16 > 16 > 16 8 < 1 > 8 > 32 > 8 < 2 < 0.5 0.5 < 2 > 16 > 32 < 8
  1. PIPC: piperacillin, CAZ: ceftazidime, CFS: cefsulodin, CFPM: cefepime, CZOP: cefozopran, AZT: aztreonam, IPM: imipenem, MEPM: meropenem, TOB: tobramycin AMK: amikacin, GM: gentamicin, MINO: minocycline, LVFX: levofloxacin,, CPFX: ciprofloxacin, ST: sulfamethoxazole/trimethoprim, FOM: fosfomycin, C/S: cefoperazone/sulbactam, P/T: piperacillin/tazobactam #: P-A: Patient a, P-B: Patient B, both hospitalized in different wards unrelated to the NICU. as for P-5, -6, -7, -8, and -9, see text in the Results section, for the backgrounds of the isolates.